Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a progressively debilitating neurodegenerative disease characterized by α-synucleinopathy, which involves all districts of the brain-gut axis, including the central, autonomic and enteric nervous systems. The highly bidirectional communication between the brain and the gut is markedly influenced by the microbiome through integrated immunological, neuroendocrine and neurological processes. The gut microbiota and its relevant metabolites interact with the host via a series of biochemical and functional inputs, thereby affecting host homeostasis and health. Indeed, a dysregulated microbiota-gut-brain axis in PD might lie at the basis of gastrointestinal dysfunctions which predominantly emerge many years prior to the diagnosis, corroborating the theory that the pathological process is spread from the gut to the brain. Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing conserved motifs primarily found in microorganisms and a dysregulation in their signaling may be implicated in α-synucleinopathy, such as PD. An overstimulation of the innate immune system due to gut dysbiosis and/or small intestinal bacterial overgrowth, together with higher intestinal barrier permeability, may provoke local and systemic inflammation as well as enteric neuroglial activation, ultimately triggering the development of alpha-synuclein pathology. In this review, we provide the current knowledge regarding the relationship between the microbiota-gut–brain axis and TLRs in PD. A better understanding of the dialogue sustained by the microbiota-gut-brain axis and innate immunity via TLR signaling should bring interesting insights in the pathophysiology of PD and provide novel dietary and/or therapeutic measures aimed at shaping the gut microbiota composition, improving the intestinal epithelial barrier function and balancing the innate immune response in PD patients, in order to influence the early phases of the following neurodegenerative cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Systemic inflammation induced by intestinal inflammation and barrier disruption is key in gut–brain communication [57,58,59].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [59]
In the citing paper
“Gut dysbiosis and the consequent development of pathogenic populations within the gut microbiota, may contribute to a wide variety of pathologies, even in sites distant from the gut, ranging from bowel inflammation, to neurodegenerative diseases (including Parkinson’s disease) and cancer [43,49,50].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haddadi, R., Nayebi, A. M., & Brooshghalan, S. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.020 · Cited by 39
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Cited by
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R.-F. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 748
“[159] Moreover, colonization of germ-free mice via”
BackgroundPropionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 644
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
“It is increasingly evident that the systemic inflammation caused by the gut inflammation and intestinal barrier damage is vital for the communication between the gut and the brain [23, 90].”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
“Gut dysbiosis and the consequent develop e t f t i l ti s it i t e t microbiota, ay t i te to a wide variety of pathologies, even in sites distant from the gut, ranging from bowel inflammation, to neurodegenerative diseases (including Parkinson’s disease) and cancer [43,49,50].”
BackgroundGut microbial molecules in behavioural and neurodegenerative conditions
Needham, B. D., Kaddurah-Daouk, R., & Mazmanian, S. K. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00381-0 · Cited by 379
The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases
Sarkar, A., Yoo, J. Y., Valeria Ozorio Dutra, S., Morgan, K. H., & Groer, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030459 · Cited by 342
“Some 20 years prior to receiving a clinical diagnosis of PD, a person developing PD usually experiences functional gastrointestinal symptoms, such as constipation, which has been linked to dysbiosis [183], then years later, a constellation of symptoms such as hand tremor, bradykinesia, muscle rigidity, masked facies,…”
BackgroundBreast Cancer and Its Relationship with the Microbiota
Fernández, M. F., Reina-Pérez, I., Astorga, J. M., Rodríguez-Carrillo, A., Plaza-Díaz, J., & Fontana, L. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081747 · Cited by 350
“Human bacterial composition contributes and affects different diseases including metabolic disorders, inflammatory and autoimmune diseases, and allergy [24], and even diseases where microbiota involvement seems unlikely [25,26].”
BackgroundShandilya, S., Kumar, S., Kumar Jha, N., Kumar Kesari, K., & Ruokolainen, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.005 · Cited by 290
“in developing disease symptoms in PD, autism spectrum disorder (ASD) and synucleinopathy models [106].”
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Luchner, M., Reinke, S., & Milicic, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020142 · Cited by 285
Role of Microglia TLRs in Neurodegeneration
Fiebich, B. L., Batista, C. R. A., Saliba, S. W., Yousif, N. M., & de Oliveira, A. C. P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00329 · Cited by 291
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275
“TLRs are innate immune system receptors, presenting in various human cells and tissues, including immune, epithelial, neural, and glial cells [9].”
BackgroundMechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia
Aneman, I., Pienaar, D., Suvakov, S., Simic, T. P., Garovic, V. D., & McClements, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01864 · Cited by 234
The Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920928984 · Cited by 221
Dysbiosis of gut microbiota in a selected population of Parkinson's patients
Pietrucci, D., Cerroni, R., Unida, V., Farcomeni, A., Pierantozzi, M., Mercuri, N. B., Biocca, S., Stefani, A., & Desideri, A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.003 · Cited by 217
“LPS disrupts the homeostasis, inducing the production of pro-inflammatory cytokines that can enter the bloodstream and reach the blood-brain barrier, leading to neuroinflammation and neuronal death [2,6,27].”
BackgroundThe Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease
Tran, S. M.-S., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu13030732 · Cited by 210
“Similarly, toll-like receptors 2 and 4 (TLRs) have shown contradicting effects on amyloid-related neurotoxicity and clearance through microglial activation [225].”
BackgroundChidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Wang, L., Zhao, Z., Zhao, L., Zhao, Y., Yang, G., Wang, C., Gao, L., Niu, C., & Li, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07711 · Cited by 203
Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10040206 · Cited by 174
“It has been found that PD patients have greater intestinal permeability (gut leakiness), which might upregulate the local/systemic inflammatory response and oxidative stress induced by lipopolysaccharides (LPSs, also termed endotoxin), leading to α-synucleinopathy in the enteric nervous system [13].”
BackgroundHelicobacter pylori infection: Beyond gastric manifestations
Santos, M. L. C., de Brito, B. B., da Silva, F. A. F., Sampaio, M. M., Marques, H. S., Silva, N. O. E., Queiroz, D. M. M., & de Melo, F. F. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i28.4076 · Cited by 170
Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 148
“It has been demonstrated that constipation significantly increases the risk of developing PD [101,102].”
BackgroundProbiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 151
“Potential TLRs signaling has also been proposed that can be modulated by probiotics in relation to PD [133].”
BackgroundInfluentialTörök, N., Tanaka, M., & Vécsei, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249338 · Cited by 156
“Alterations of TRP metabolism, glutamate excitotoxicity, and the gut-brain-axis have been shown associated with the pathogenesis of PD [44,103].”
BackgroundAlpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
Fitzgerald, E., Murphy, S., & Martinson, H. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00369 · Cited by 143
“Gut Microbiota and Alpha-Synuclein Another way that the enteric microbiota has been implicated in local and systemic inflammatory processes is with bacteria derived proteins (Codolo et al., 2013; Thaiss et al., 2016a; Caputi and Giron, 2018).”
BackgroundPharmacological Targeting of Microglial Activation: New Therapeutic Approach
Liu, C.-Y., Wang, X., Liu, C., & Zhang, H.-L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 142
“Further, a multi-faceted TLR signaling network is essential for the immune-mediated processes both in the gut and in the CNS, exerting inflammatory or regulatory effects in the pathogenesis of PD (Houser and Tansey, 2017; Caputi and Giron, 2018).”
BackgroundDiet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
“Mechanistically, this appears to be the consequence of LPS-driven activation of TLR4, especially on brain microglia (201).”
BackgroundAltered gut microbiota associated with symptom severity in schizophrenia
Li, S., Zhuo, M., Huang, X., Huang, Y., Zhou, J., Xiong, D., Li, J., Liu, Y., Pan, Z., Li, H., et al. (2020) · PeerJ · doi:10.7717/peerj.9574 · Cited by 142
Zhao, Z., Li, F., Ning, J., Peng, R., Shang, J., Liu, H., Shang, M., Bao, X.-Q., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.020 · Cited by 137
The Relationship Between the Gut Microbiome and Neurodegenerative Diseases
Zhu, X., Li, B., Lou, P., Dai, T., Chen, Y., Zhuge, A., Yuan, Y., & Li, L. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00730-8 · Cited by 130
“Some studies have indicated that prebiotic fibers that generate butyrate may have beneficial effects in PD patients [24, 82, 88].”
BackgroundInfluentialThe Therapeutic Role of Ketogenic Diet in Neurological Disorders
Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska-Chmiel, I. (2022) · Nutrients · doi:10.3390/nu14091952 · Cited by 115
Gupta, R., Kumari, S., Senapati, A., Ambasta, R. K., & Kumar, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102013 · Cited by 134
The gut microbiome is associated with brain structure and function in schizophrenia
Li, S., Song, J., Ke, P., Kong, L., Lei, B., Zhou, J., Huang, Y., Li, H., Li, G., Chen, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89166-8 · Cited by 145
The Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 125
Gut microbiota and neurological effects of glyphosate
Rueda‐Ruzafa, L., Cruz, F., Román, P., & Cardona, D. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.006 · Cited by 135
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Dogra, N., Mani, R. J., & Katare, D. P. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01066-7 · Cited by 133
The Impact of Microbiota on the Gut–Brain Axis: Examining the Complex Interplay and Implications
Chaudhry, T. S., Senapati, S. G., Gadam, S., Mannam, H. P. S. S., Voruganti, H. V., Abbasi, Z., Abhinav, T., Challa, A. B., Pallipamu, N., Bheemisetty, N., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165231 · Cited by 121
“The pathophysiology of alpha-synucleinopathies is also thought to include malfunctioning of Toll-like receptor signaling [62].”
BackgroundBistoletti, M., Caputi, V., Baranzini, N., Marchesi, N., Filpa, V., Marsilio, I., Cerantola, S., Terova, G., Baj, A., Grimaldi, A., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212856 · Cited by 106
Self-citationTh17 cells and inflammation in neurological disorders: Possible mechanisms of action
Shi, Y., Wei, B., Li, L., Wang, B., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932152 · Cited by 108
“Indeed, alterations of Th17 cells in the gut microbiota have been documented in several diseases such as AD (60), PD (61), and MS (62).”
BackgroundTLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
Gorecki, A. M., Anyaegbu, C. C., & Anderton, R. S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00271-0 · Cited by 103
“Activation of TLRs by PAMPs and DAMPs is crucial for pathogen defence and tissue repair throughout the body; however, dysfunctional or excessive TLR activation and downstream signalling can contribute to various autoimmune, inflammatory, and age-associated diseases in various body systems, such as PD [4, 5, 39].”
BackgroundInfluentialEV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production
Luo, Z., Su, R., Wang, W., Liang, Y., Zeng, X., Shereen, M. A., Bashir, N., Zhang, Q., Zhao, L., Wu, K., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1008142 · Cited by 100
“Emerging evidence suggests that TLRs play fundamental roles in brain development and homeostasis [28, 35, 36].”
BackgroundNeuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Hou, Y., Li, X., Liu, C., Zhang, M., Zhang, X., Ge, S., & Zhao, L. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111376 · Cited by 101
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Mehrabadi, S., Department of Physiology, S. O. M., Sadr, S. S., & Department of Physiology, S. O. M. (2020) · Iranian Biomedical Journal · doi:10.29252/ibj.24.4.220 · Cited by 93
Interactions between the microbiota and enteric nervous system during gut-brain disorders
Fried, S. G., Wemelle, E., Cani, P. D., & Knauf, C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108721 · Cited by 102
Müller, H., Dagher, G., Loibner, M., Stumptner, C., Kungl, P., & Zatloukal, K. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.004 · Cited by 99
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 88
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Inczefi, O., Bacsúr, P., Resál, T., Keresztes, C., & Molnár, T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.718710 · Cited by 98
“Toll-like receptor misrecognition is considered to be an important step in alpha-synucleinopathy progression, and increased intestinal permeability, immune activation, and enteric neuroglial activation are keys in the pathophysiology of Parkinson’s disease (158).”
BackgroundMahbub, N. U., Islam, M. M., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1348279 · Cited by 97
“In recent years, mounting evidence has accentuated the relevance of the gut-brain axis and gut microbiome in Parkinson ’ s disease (PD) development and advancement (Caputi and Giron, 2018; Menozzi et al., 2021; Nielsen et al., 2021; Tan et al., 2022; Li et al., 2023).”
BackgroundGuo, B., Zhang, J., Zhang, W., Chen, F., & Liu, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272769 · Cited by 96
“Valeric acid and caproic acid can improve the relative abundance of Prevotella spp. and Coprococcus spp., while inhibiting the multiplication of Clostridioides difficile, which are closely related to NDDs (Caputi and Giron 2018; Yadav et al. 2022).”
Spectrum of Non-Motor Symptoms in Parkinson's Disease
Kumaresan, M., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.13275 · Cited by 108
“Caputi and Grion [13] 2018 Review Newer treatment Microbiome-gut-brain”
BackgroundReview of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 95
“…motor nucleus of the vagus nerve and substantia nigra, further demonstrates the important role of the gut brain axis in regulating PD. Notably, disordered gut microbiota can lead to increased deposition of synaptic nucleoprotein, leading to in fl ammation and further PD (Caputi and Giron, 2018).”
BackgroundAnti-hypertensive peptides released from milk proteins by probiotics
Ahtesh, F. B., Stojanovska, L., & Apostolopoulos, V. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.06.016 · Cited by 86
“syndrome [43], Parkinson’s disease [44] and multiple sclerosis [45].”
BackgroundMicrobiome, Parkinson’s Disease and Molecular Mimicry
Miraglia, F., & Colla, E. (2019) · Cells · doi:10.3390/cells8030222 · Cited by 90
“Although it is not clear if αS antigenic potential needs a primed immune system in the gut, because of the importance of neuroinflammation and TRLs in PD, therapeutic intervention targeting downregulation of TRLs signaling is under review [140], and could represent a unique strategy to counteract both gut and brain in…”
BackgroundMicrobiota and Ocular Diseases
Xue, W., Li, J. J., Zou, Y., Zou, B., & Wei, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759333 · Cited by 90
“Considerable evidence demonstrates the roles of microbes in Alzheimer’s disease, Parkinson’s disease, and autism, corroborating the theory of the gut microbiota-brain axis (Caputi and Giron, 2018; Angelucci et al., 2019; Morais et al., 2021).”
BackgroundMicrobiota and Obesity: Where Are We Now?
Ballini, A., Scacco, S., Boccellino, M., Santacroce, L., & Arrigoni, R. (2020) · Biology · doi:10.3390/biology9120415 · Cited by 88
“Gut microbiota alterations have been found not only in obesity but in multiple pathologies, ranging from intestinal bowel syndrome (IBS), type 2 diabetes (T2D) [18–23], and cardiovascular diseases [24] to Parkinson [25].”
BackgroundWei, Z., Li, F., & Pi, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.812596 · Cited by 86
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 75
“Additionally, on the other side of the barrier, immune cells responded to Curli, which caused the expression of IL-17 and IL-22, which have been shown to regulate barrier function in a TLR2-dependent manner (Tursi and Tükel, 2018).”
BackgroundInfluentialDietary Influences on the Microbiota–Gut–Brain Axis
Barber, T. M., Valsamakis, G., Mastorakos, G. P., Hanson, P., Kyrou, I., Randeva, H. S., & Weickert, M. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073502 · Cited by 84
“Indeed, the gut microbiota is implicated in the pathogenesis of many neuro-psychiatric disorders, including Parkinson’s disease [15], autism spectrum disorder [16], chronic pain [17] and disorders of mood and affect [18].”
BackgroundSadovnikova, I. S., Gureev, A. P., Ignatyeva, D. A., Gryaznova, M. V., Chernyshova, E. V., Krutskikh, E. P., Novikova, A. G., & Popov, V. N. (2021) · Pharmaceuticals · doi:10.3390/ph14070607 · Cited by 73
“This effect was shown for mild cognitive impairments [21], Alzheimer’s disease [22], Parkinson’s disease [23], depression [24], and schizophrenia [25].”
BackgroundLi, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76
Soraci, L., Gambuzza, M. E., Biscetti, L., Laganà, P., Russo, C. L., Buda, A., Barresi, G., Corsonello, A., Lattanzio, F., Lorello, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11491-3 · Cited by 78
“To this regard, disruption of the brain–gut axis secondary to intestinal microbial dysbiosis is recently emerging as a contributing factor in PD pathogenesis [62]; alteration of gut microbiota and gut epithelial barrier induces activation of enteric TLRs, thus promoting inflammation and oxidative stress in both gut an…”
BackgroundMicrobiota and Phage Therapy: Future Challenges in Medicine
Paule, A., Frezza, D., & Edeas, M. A. (2018) · Medical Sciences · doi:10.3390/medsci6040086 · Cited by 90
“Additionally, the leaky gut syndrome should be taken into consideration as observed in Alzheimer’s [11] and Parkinson’s [12] diseases.”
BackgroundRole of exosomes in the pathogenesis of inflammation in Parkinson’s disease
Yang, X., Li, K., Huang, H., & Ren, H. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335143 · Cited by 74
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · Cells · doi:10.3390/cells14151161 · Cited by 56
Composition and diversity of gut microbiota in diabetic retinopathy
Bai, J., Wan, Z., Zhang, Y., Wang, T., Xue, Y., & Peng, Q. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.926926 · Cited by 70
“…and the pathogenesis of several human systemic diseases, including inflammatory bowel disease (Halfvarson et al., 2017), irritable bowel syndrome (Bernstein and Forbes, 2017), Alzheimer’s disease (Wang et al., 2019), Parkinson’s disease (Caputi and Giron, 2018), and depression (Zheng et al., 2020).”
BackgroundLayunta, E., Buey, B., Mesonero, J. E., & Latorre, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.748254 · Cited by 72
Gastrointestinal Immunity and Alpha-Synuclein
Barbut, D., Stolzenberg, E. D., & ZASLOFF, M. A. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191702 · Cited by 71
“As yet we do not know the mechanisms that are involved in the induction of neuronal S by infection, such as the role of TLRs (which are present on neurons) [29, 30], or the release of pro-inflammatory mediators, such as IL-17 and IL22 (which potently stimulate induction of epithelial AMPs) [31].”
BackgroundMicrobiome and Cognitive Impairment: Can Any Diets Influence Learning Processes in a Positive Way?
Novotný, M., Klimova, B., & Valis, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00170 · Cited by 68
“TLRs-mediated signaling results in the induction of dendritic cells and subsequent cytokine production (Thomas et al., 2017; Caputi and Giron, 2018).”
BackgroundSalami, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.613120 · Cited by 67
“Toll-like receptor ligands derived from the probiotics are also shown to display positive effect on production of the anti-inflammatory cytokines (Thomas et al., 2017; Caputi and Giron, 2018).”
BackgroundNew hope for Parkinson’s disease treatment: Targeting gut microbiota
Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13916 · Cited by 66
Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials
Park, K. J., & Gao, Y. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1481390 · Cited by 71
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 56
“A decrease in Prevotellaceae in PD patients may be related to the reduction in mucin production defining an amplified intestinal permeability, known also as “leaky gut”, that can be associated with α-synuclein aggregates through the bacteria translocation and the production of bacterial products that induce inflammati…”
BackgroundBlood–brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research
Peng, B., Hao, S., Tong, Z., Bai, H., Pan, S., Lim, K., Li, L., Voelcker, N. H., & Huang, W. (2022) · Lab on a Chip · doi:10.1039/d2lc00305h · Cited by 71
“Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease
Oppo, V., Melis, M., Melis, M., Barbarossa, I. T., & Cossu, G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00043 · Cited by 69
“A cross-talk between signaling from T2Rs and toll-like receptors (TLRs) has been proposed by several authors (Lee and Cohen, 2015; Caputi and Giron, 2018; Maina et al., 2018).”
BackgroundRiccio, P., & Rossano, R. (2019) · Nutrients · doi:10.3390/nu11112714 · Cited by 70
“In addition to SCFAs, other molecules that may influence TLRs signaling and suppress neuroinflammation may be docoexanoic acid (DHA), a polyunsaturated omega-3 fatty acid, some probiotics, prebiotics such as fructo- and galacto-oligosaccharides (FOS and GOS) [96].”
BackgroundGut Microbiota and Neuroplasticity
Murciano-Brea, J., García-Montes, M. E., Geuna, S., & Herrera‐Rincon, C. (2021) · Cells · doi:10.3390/cells10082084 · Cited by 66
Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
Dabi, Y. T., Ajagbe͓, A. O., & Degechisa, S. T. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.839 · Cited by 65
“unknown, mounting evidence suggests that misfolded α‐ synuclein activates microglial cells in the substantia nigra pars compacta (SNc), causing them to become more inflamed and under oxidative stress, which in turn causes neurodegeneration.(14) TLR2 is the most studied neuronal TLR in the context of PD pathology.”
BackgroundResultInfluentialThe gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
Asseri, A. H., Bakhsh, T., Abuzahrah, S. S., Ali, S., & Rather, I. A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1208044 · Cited by 59
“Gut dysbiosis can lead to inflammation of the gut, neurodegenerative diseases (such as Parkinson’s disease), and cancer due to the emergence of pathogenic populations within the gut microbiota, even at distant sites (Dembiński et al., 2016; Lane et al., 2017; Caputi and Giron, 2018; Yan et al., 2022).”
BackgroundYang, B., Zhang, L., Chen, Y., Bai, Y., Jia, J., Feng, J., Liu, K., & Zhou, J. F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106596 · Cited by 59
Kaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 63
“The spread of these immune sensors illustrates neural cells' potential for sustaining immune stimulus and their critical emphasis in maintaining the homeostasis [116, 56, 118, 119].”
BackgroundParkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration
Jauhari, A., Singh, T., Mishra, S., Shankar, J., & Yadav, S. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa066 · Cited by 60
Clinical Trials of Probiotic Strains in Selected Disease Entities
Dudek-Wicher, R., Junka, A., Paleczny, J., & Bartoszewicz, M. (2020) · International Journal of Microbiology · doi:10.1155/2020/8854119 · Cited by 51
“*erefore, they can be important in preventing the degeneration of neurons [35].”
BackgroundHattori, N., & Yamashiro, Y. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000512226 · Cited by 57
Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
Castillo-Rangel, C., Marín, G., Hernández-Contreras, K. A., Vichi-Ramírez, M. M., Zarate-Calderon, C., Torres-Pineda, O., Díaz-Chiguer, D. L., González, D. D. L. M., Apo, E. G., Teco-Cortes, J. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065792 · Cited by 60
“This process highlights the relevance of understanding the functioning of the gut–brain axis—particularly the products of microbial metabolism, such as short-chain fatty acids (SCFAs) and tryptophan metabolites that impact neuronal activity and neuroin-flammation [48,64,65].”
BackgroundSingh, N., Singh, V., Nand, S., Mishra, V., Vamanu, E., & Singh, M. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113958 · Cited by 57
The complex relationship between gut microbiota and Alzheimer’s disease: A systematic review
Zhou, X.-P., Sun, L.-B., Liu, W., Zhu, W.-M., Li, L.-C., Song, X., Xing, J.-P., & Gao, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102637 · Cited by 57
“This cascade results in impaired glucose metabolism and neuronal cell death, and subsequently, ultimately damages the nervous system (Caputi and Giron, 2018).”
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., & Gaskill, P. J. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100030 · Cited by 62
Danilenko, V., Devyatkin, A., Marsova, M., Shibilova, M., Ilyasov, R. A., & Shmyrev, V. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s333887 · Cited by 57
Nyatega, C. O., Qiang, L., Adamu, M. J., & Kawuwa, H. B. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1027907 · Cited by 57
“Alteration in TRP metabolism, glutamate excitotoxicity, and the gut-brain axis have been linked to the etiology of PD (17, 18).”
BackgroundInflammatory bowel disease: A potential pathogenic factor of Alzheimer's disease
Wang, D., Zhang, X., & Du, H. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110610 · Cited by 57
Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders
Chandra, S., Alam, M. T., Dey, J., Sasidharan, B. C. P., Ray, U., Srivastava, A. K., Gandhi, S., & Tripathi, P. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200413091101 · Cited by 52
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 51
“Gut dysbiosis and/or small intestinal overgrowth have been suggested to induce over-response of the immune system and consequently systemic and/or CNS inflammation [32,47].”
BackgroundBordoni, L., Gabbianelli, R., Fedeli, D., Fiorini, D., Bergheim, I., Jin, C. J., Marinelli, L., Stefano, A. D., & Nasuti, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223238 · Cited by 51
Rani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 50
Ishola, I. O., Awogbindin, I. O., Olubodun-Obadun, T. G., Oluwafemi, O. A., Onuelu, J. E., & Adeyemi, O. O. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147958 · Cited by 50
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 48
Association of Parkinson’s Disease With Microbes and Microbiological Therapy
Chen, Z.-J., Liang, C.-Y., Yang, L.-Q., Ren, S.-M., Xia, Y.-M., Cui, L., Li, X.-F., & Gao, B.-L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.619354 · Cited by 45
“Enterobacteriaceae and bacteroidia are believed to increase the endotoxin in the body of PD patients, promote release of inflammatory cytokines in the body, and, with blood circulation through the blood-brain barrier, further induce nerve inflammation and nerve death (Choi et al., 2016; Caputi and Giron, 2018).”
BackgroundRaval, U., Harary, J. M., Zeng, E., & Pasinetti, G. M. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1775585 · Cited by 45
Metadata
- Authors
- Caputi, V., & Giron, M. C.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Giron, Maria Cecilia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-06-06
- Volume
- 19
- Issue
- 6
- Pages
- 1689
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6032048
- OpenAlex
- W2807153072
- Cited by
- 338
- References
- 140
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 57 · 2021: 69 · 2020: 43 · 2019: 29 · 2018: 8
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Università degli Studi di Padova (PRID Grant 2017, Assegno di Ricerca 2016)
- San Camillo Hospital, Treviso (Italy) (Grant 2015)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, microbiota-gut-brain axis, Toll-like receptors, synucleinopathies, gut dysbiosis, small intestinal bacterial overgrowth, intestinal permeability, innate immunity, neuroinflammation, gastrointestinal dysfunction, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Brain, Humans, Immunity, Innate, Parkinson Disease, Probiotics, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.